| Literature DB >> 34609489 |
Chengming Zhang1,2, Hong Zhang3, Jing Ge1, Tingyan Mi3, Xiao Cui3, Fengjuan Tu3, Xuelan Gu3, Tao Zeng4, Luonan Chen1,5,6,7.
Abstract
Skin, as the outmost layer of human body, is frequently exposed to environmental stressors including pollutants and ultraviolet (UV), which could lead to skin disorders. Generally, skin response process to ultraviolet B (UVB) irradiation is a nonlinear dynamic process, with unknown underlying molecular mechanism of critical transition. Here, the landscape dynamic network biomarker (l-DNB) analysis of time series transcriptome data on 3D skin model was conducted to reveal the complicated process of skin response to UV irradiation at both molecular and network levels. The advanced l-DNB analysis approach showed that: (i) there was a tipping point before critical transition state during pigmentation process, validated by 3D skin model; (ii) 13 core DNB genes were identified to detect the tipping point as a network biomarker, supported by computational assessment; (iii) core DNB genes such as COL7A1 and CTNNB1 can effectively predict skin lightening, validated by independent human skin data. Overall, this study provides new insights for skin response to repetitive UVB irradiation, including dynamic pathway pattern, biphasic response, and DNBs for skin lightening change, and enables us to further understand the skin resilience process after external stress.Entities:
Keywords: UVB irradiation; living skin equivalent model; single-sample network; skin lightening; time series data; tipping point
Mesh:
Substances:
Year: 2022 PMID: 34609489 PMCID: PMC8782598 DOI: 10.1093/jmcb/mjab060
Source DB: PubMed Journal: J Mol Cell Biol ISSN: 1759-4685 Impact factor: 6.216
Figure 1Framework of LSE experiment and l-DNB data analysis. (A) Schematic diagram of the experimental design on 3D skin model. (B) The flowchart of landscape l-DNB method to identify DNB genes from a single sample and validation from different aspects.
Figure 2Skin transcriptome changes during UVB irradiation revealed by differential expression analysis. (A and B) Repetitive UVB irradiation results in a consecutive decline of L* (A) and increased melanin content (B). (C) PCA of whole-genome gene expression. Blue nodes: samples from control group; red nodes: samples from UVB group. Number on each node: sampling time (day). CON, Control. (D) Heatmap of DEGs for all samples. D1-1h-U represents the sample from UVB group at first hour of Day 1. D1-1h-C represents the sample from control group at first hour of Day 1. (E) Dynamic pattern of global pathways involving DEGs and the specific pathway involvement. Blue node on network: DEGs at corresponding time point. The height of bar: involvement based on P-value from IPA pathway analysis at corresponding time. (F) Dynamic involvement of prioritized pathways over time.
Figure 3Tipping point of skin transcriptome dynamics during UVB irradiation identified by l-DNB analysis. (A) PCA based on SSN edge statistics. Blue nodes: samples from control group; red nodes: samples from UVB group. Number on each node: sampling time (day). (B) Average DNB scores for UVB samples. (C) The landscape of DNB genes for UVB samples. (D) DNB genes-involved pathways. (E) TP-DEGs-involved pathways. −Log(P) is the pathway enrichment/involvement significance through IPA analysis.
Figure 4Identification of DNB network and core DNB genes responding to UVB irradiation. (A) SSN overview among all time points (red: DNB score for each gene). (B) Overlap between DNB and skin-related signature genes. (C) A dynamic endogenous core DNB network. (D) Upstream factor of DNB genes among core DNB genes with their regulated DNB genes. Green: downregulated at the specific time. Orange node: upregulated at the specific time.
Figure 5Assessments of the tipping point and core DNB genes of skin response to UVB irradiation. (A) DNB scores calculated by just core DNB genes or by all candidate DNB genes. (B) Comparison of the onset time and efficacy between USBT2627 treatments before and after the tipping point. Onset time: the time when skin sample showed significant increase of L*. Efficacy: normalized increasement of L* in USBT2627 group compared to UVB group at onset time. (C) Melanin staining between USBT2627 treatments before and after the tipping point.